first glp-1 approved for weight loss A diabetes drug. Then a weight-loss drug. Then a global blockbuster. Here's how GLP-1s went from helping manage blood sugar to becoming one of medicine's biggest stories. [GLP-1, Ozempic, Wegovy, Mounjaro, diabetes Wegovy Pill Wins FDA Approval

Feng X, McDonald JM

Does the cost of semaglutide change if I need a higher dose

Key takeaways Medicaid usually only covers GLP-1s if you are taking them for health conditions like Type 2 diabetes, cardiovascular risk reduction, or sleep apnea

(Michael Siluk/UCG/Universal Images Group via Getty Images / Getty Images) NOVO NORDISK TO SELL WEIGHT-LOSS DRUG FOR $499 TO ELIGIBLE CUSTOMERS Novo Nordisk is a Danish healthcare company which develops treatments for an array of illnesses, including diabetes and obesity drugs

The mechanisms underlying GLP-1-associated heart rate increases are multifactorial and not fully understood